Ebumnuche abụọ na-eduga mgbanwe ahụike metabolic. Tirzepatide (2023788-19-2) aghọọla eze ọgwụ, na-enye ụlọ ọrụ ọgwụ zuru ụwa ọnụ ike ịkwalite

▶ Usoro ọgwụgwọ ọrịa metabolic zuru ụwa ọnụ ahụla ọganihu ugboro ugboro. Usoro ọgwụgwọ GLP-1/GIP nke abụọ na-aga n'ihu na-agbawa agbawa. Dịka ngwaahịa kachasị na ngalaba a, Tirzepatide (tirzepatide, nọmba CAS: Na 2023788-19-2), yana uru pụrụ iche nke njikọta abụọ, arụmọrụ ọgwụgwọ pụrụ iche na arụmọrụ ahịa na-agbawa agbawa, o nwetara aha "Eze Ọgwụ" zuru ụwa ọnụ nke ọma, na-aghọ isi ihe a na-elekwasị anya na ngalaba nyocha na mmepe ọgwụ, ojiji ụlọ ọgwụ na mmepụta kemịkalụ, na ịkwalite ntinye nke ọgwụgwọ ahụike metabolic n'ime oge ọhụrụ nke "njikọ abụọ na-aga n'ihu".
Tirzepatide bụ GLP-1 (peptide-like glucagon-like-1) /GIP (glucose-dependent insulinotropic polypeptide) nke e ji aka rụọ ogologo oge, nke dị na ụdị polypeptide compound. Usoro kemịkalụ ya bụ CHNOS, nwere ibu molekul nke ihe dị ka 6,563.0 na ịdị ọcha nke ihe karịrị 98.0%. Ọ na-apụta dị ka ntụ ọcha. Ọ na-agbaze nke ukwuu na mmiri. N'ọnọdụ okpomọkụ ụlọ, a ga-echekwa ya n'ime akpa mechiri emechi pụọ na ìhè iji hụ na ọ na-arụ ọrụ ndụ. N'adịghị ka otu ndị na-anabata GLP-1, Tirzepatide na-enweta mmetụta synergistic site na ilekwasị anya kpọmkwem na ebumnuche metabolic abụọ dị mkpa, GLP-1 na GIP. Onye nnata GLP-1 na-ahụ maka igbochi agụụ na igbu oge mmịpụta afọ, ebe onye nnata GIP nwere ike imeziwanye mmetụta insulin ma belata mkpokọta abụba. Usoro abụọ nke ọrụ na-eme ka mmụba dị elu na mmetụta ọgwụgwọ. Ka ọ dị ugbu a, site na mgbanwe nhazi, ọkara ndụ n'ime ahụ na-adịte aka, na-enye ohere maka ịgba ọgwụ n'okpuru ala otu ugboro n'izu, nke na-eme ka nnabata ọgwụ nke ndị ọrịa dịkwuo mma.

▶ N'ihe gbasara ojiji ọgwụgwọ, a chọpụtala uru Tirzepatide nke ọma site na ọtụtụ nnwale ụlọọgwụ kachasị elu n'ụwa niile, na-emepụta usoro ọgwụgwọ nke usoro abụọ bụ isi nke mbelata shuga ọbara na mbelata ibu na-eduzi. Dịka ọgwụ ọhụrụ maka ọgwụgwọ ọrịa shuga ụdị nke abụọ, ọ na-ebelata ọkwa nke glycated hemoglobin (HbA1c) n'ime ndị ọrịa site na ịchịkwa insulin na glucagon na-emepụta n'ụzọ dabere na glucose. Nnwale ụlọọgwụ ndị dị mkpa egosila na dose nke 5-15 mg otu ugboro n'izu nwere ike ibelata HbA1c site na 1.8% ruo 2.1%, ihe ize ndụ nke hypoglycemia dịkwa ala karịa nke ọgwụ hypoglycemic ọdịnala. N'ihe gbasara mbelata ibu, uru ya pụtakwara ìhè karịa. Ọmụmụ SURMOUNT 5 nke e bipụtara na New England Journal of Medicine gosiri na na izu 72, nkezi oke mbelata ibu nke otu ọgwụgwọ Tirzepatide ruru 20.2%, yana nkezi mbelata ibu nke 22.8kg, nke ka mma karịa nke otu agonist onye na-anabata GLP-1. Ọ na-enye nhọrọ ọgwụgwọ dị irè karị maka ndị buru ibu na ndị buru ibu. Tinyere nke ahụ, Tirzepatide enwetala nsonaazụ dị ịrịba ama na nyocha ahụike n'akụkụ dịka nchekwa obi, ọrịa imeju abụba metụtara metabolism (MASLD), na nsogbu iku ume metụtara oke ibu, na-agbasawanye ókè ojiji ya na ọgwụgwọ ma na-egosipụta njirimara ya zuru oke nke "ịgwọ ọtụtụ ọrịa site na otu ọgwụ".

▶ Na mgbakwunye na ojiji ya maka ọgwụgwọ ahụike, a na-enyocha ike nyocha sayensị nke Tirzepatide mgbe niile, ebe ojiji ya na-agbasakwa mgbe niile. Nnyocha achọpụtala na ihe mejupụtara a nwere ike ịgafe ihe mgbochi ọbara-ụbụrụ ma gosipụta uru dị na ọmụmụ nke ọrịa neurodegenerative, a na-atụkwa anya na ọ ga-enye ntụziaka ọhụrụ maka ọgwụgwọ ọrịa dịka ọrịa Parkinson na ọrịa Alzheimer. Na nyocha gbasara ọgwụgwọ nke ọrịa imeju abụba metụtara metabolism (MASLD), Tirzepatide na-egbochi mmepụta abụba n'ime imeju site na ịchịkwa enzymes dị mkpa na metabolism lipid. Nnwale ahụike ndị dị mkpa egosila na ọ nwere ike ibelata ọdịnaya abụba imeju nke ọma, na-eweta olileanya ọhụrụ maka ọgwụgwọ nke ọrịa imeju. Na mgbakwunye, a na-enyochakwa uru nyocha sayensị ya na mgbochi na ọgwụgwọ nke nsogbu dịka ọrịa obi na ọrịa akụrụ na-adịghị ala ala, na-enye ebe ntinye ọhụrụ maka nyocha dị iche iche.

▶ N'akụkụ ụlọ ọrụ mmepụta ihe, site na mmụba ngwa ngwa nke ahịa ọrịa metabolic zuru ụwa ọnụ, mmepụta na ikike ọkọnọ nke Tirzepatide anọgidewo na-aka mma, arụmọrụ ahịa ya egosikwala mmụba dị egwu. Dịka data ụlọ ọrụ si kwuo, ahịa Tirzepatide kwa afọ rịrị elu ruo ijeri dọla US 36.507 na 2025, nke gafere semaglutide iji bụrụ "eze ọgwụ" zuru ụwa ọnụ. N'ime ha, ahịa nke ụdị hypoglycemic (Mounjaro) bụ ijeri dọla US 22.965, ahịa nke ụdị mbelata ibu (Zepbound) bụ ijeri dọla US 13.542. Ha mụbara site na 99% na 175% n'otu n'otu kwa afọ. Ugbu a, ọtụtụ ụlọ ọrụ ime obodo na-eme ka mmepụta ụlọ ọrụ mmepụta ihe nke Tirzepatide dị ngwa ngwa. Eli Lilly na-etinyekwa ego ijeri yuan 1.5 iji gbasaa ụlọ ọrụ mmepụta ihe ya na Suzhou ma kwalite usoro mmepụta mpaghara nke "Mere na China Tirzepatide". Ụfọdụ ụlọ ọrụ ime obodo enwetala ọganihu na teknụzụ ndị metụtara ya, na-akwado mgbanwe dị iche iche dị ka ịkọ biotin na ịkọ fluorescence. Ịdị ọcha nke ngwaahịa a karịrị 99%, nke nwere ike izute mkpa nyocha na mmepụta ahaziri iche ma mee ka usoro nhazi nke ngwaahịa a dị ngwa ngwa.

▶ Ndị ọkachamara n'ihe gbasara ọgwụ na-ekwu na mmụba nke Tirzepatide (2023788-19-2) abụghị naanị ịgbanwe ọdịdị ọgwụgwọ nke ọrịa metabolic, kamakwa ọ kwalitere mmelite ugboro ugboro nke nyocha na mmepe nke ọgwụ peptide, na-egosi na ahịa ọgwụ zuru ụwa ọnụ abanyela n'ihu ọha "oge metabolic" site na "oge mgbochi kansa". Usoro ọhụrụ ya nke njikọta ihe mgbaru ọsọ abụọ na-enye echiche ọhụrụ maka nyocha na mmepe nke ọgwụ peptide na-esote, uto ahịa na-agbawa agbawa na-egosikwa nnukwu ọchịchọ n'ọhịa nke ọrịa metabolic. N'ọdịnihu, site na mmụba na-aga n'ihu nke nyocha sayensị na mmezi teknụzụ mmepụta na-aga n'ihu, Tirzepatide ga-enweta ọganihu na ngalaba ọrịa ndị metụtara metabolism. N'otu oge ahụ, mmụba nke usoro mmepụta ụlọ ga-ebelata ọnụ ahịa ngwa ya, na-etinye mkpali ọhụrụ na mmepe dị elu nke ụlọ ọrụ ọgwụ na ahụike zuru ụwa ọnụ.

▶ A kọrọ na usoro zuru oke nke usoro ọkọnọ Tirzepatide aghọọla nke nta nke nta n'ahịa, na-ekpuchi ọtụtụ njikọ dịka mmepụta ihe eji emepụta ihe, nyocha na mmepe nhazi, na inye ihe ndị na-emepụta nyocha sayensị. Ụlọ ọrụ ndị dị mkpa na-ahụ na ngwaahịa ha na-erube isi n'ụkpụrụ mba ụwa site na sistemụ njikwa mma siri ike, na-enye nkwado a pụrụ ịdabere na ya maka ngwa ahụike na ọrụ nyocha sayensị, ma na-enye aka na ọganihu na-aga n'ihu nke nyocha ahụike na ahụike zuru ụwa ọnụ.